...
首页> 外文期刊>Biochemical Pharmacology >Heme oxygenase-1 induction by rosiglitazone via PKC alpha/AMPK alpha/p38 MAPK alpha/SIRT1/PPAR gamma pathway suppresses lipopolysaccharide-mediated pulmonary inflammation
【24h】

Heme oxygenase-1 induction by rosiglitazone via PKC alpha/AMPK alpha/p38 MAPK alpha/SIRT1/PPAR gamma pathway suppresses lipopolysaccharide-mediated pulmonary inflammation

机译:血红素氧基酶-1通过PKCα/ AMPKα/ P38 MAPKα/ SIRT1 / PPARγ途径抑制脂多糖介导的肺炎症

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

HO-1 (heme oxygenase-1), an antioxidant enzyme, induced by rosiglitazone (PPAR ligands) can be a potential treatment of inflammation. However, the mechanisms of rosiglitazone-induced HO-1 expression in human pulmonary alveolar epithelial cells (HPAEpiCs) remain largely unknown. In this study, we found that upregulation of HO-1 in vitro or in vivo by rosiglitazone attenuated VCAM-1 gene expression and monocyte adhesion to HPAEpiCs challenged with lipopolysaccharide (LPS). The inhibitory effects of rosiglitazone on LPS-mediated responses were reversed by transfection with HO-1 siRNA. LPS-induced VCAM-1 expression was mediated through NF-kappa B activation which was attenuated by rosiglitazone via suppressing p65 activation and translocation into the nucleus. Moreover, pretreatment with the inhibitor of PKCs (H7), PKC alpha (Go6976), AMPK alpha (Compound C), p38 MAPK alpha (p38i VIII), SIRT1 (Sirtinol), or PPAR gamma (T0070907) and transfection with siRNA of PKC alpha, AMPK alpha, p38 MAPK alpha, SIRT1, or PPAR gamma abolished the rosiglitazone-induced HO-1 expression in HPAEpiCs. Further studies indicated that rosiglitazone stimulated SIRT1 deacetylase leading to PGClatranslocation from the cytosol into the nucleus, promoting fragmentation of NCoR and phosphorylation of PPARy. Subsequently, PPAR gamma was activated by phosphorylation of PKC alpha, AMPK alpha, p38 MAPK alpha, and SIRT1, which turned on transcription of HO-1 gene by binding to PPAR gamma response element (PPRE) and enhancing PPAR gamma promoter activity. These results suggested that rosiglitazone-induced HO-1 expression is mediated through PKC alpha/AMPK alpha/p38 MAPKct/ SIRT1-dependent deacetylation of Ac-PGC1 alpha and fragmentation of NCoR/PPAR gamma activation in HPAEpiCs. Up-regulation of HO-1 protected against the inflammatory responses triggered by LPS, at least in part, through attenuation of NF-kappa B. (C) 2018 Elsevier Inc. All rights reserved.
机译:HO-1(血红素氧酶-1),罗格列酮(PPAR配体)诱导的抗氧化酶可以是炎症的潜在处理。然而,人肺肺泡上皮细胞(HPApics)中的罗格列酮诱导的HO-1表达的机制仍然很大程度上是未知的。在这项研究中,我们发现,通过罗格列唑和体内的HO-1衰减VCAM-1基因表达和用脂多糖(LPS)攻击的HPApics的单核细胞粘附,对HPApics的粘附性上调。 Rosiglitazone对LPS介导的反应对LPS介导的反应的抑制作用通过转染HO-1 siRNA而逆转。 LPS诱导的VCAM-1表达通过NF-Kappa B激活介导,所述NF-Kappa B激活通过罗格列酮通过抑制p65活化和易位蒸发到细胞核中。此外,对PKCS(H7),PKCα(GO6976),AMPKα(化合物C),P38MAPKα(P38i VIII),SIRT1(SIRTINOL)或PPARγ(T0070907)的抑制剂进行预处理,并用PKC的siRNA转染Alpha,AMPK Alpha,P38 Mapk Alpha,SIRT1或PPAR Gamma废除了HPAepics中的Rosiglitazone诱导的HO-1表达。进一步的研究表明,Rosiglitazone刺激了SIRT1脱乙酰化酶,导致来自胞嘧啶的PGClatransLocation进入细胞核,促进Ncor的破碎化和PPARA的磷酸化。随后,通过PKCα,AMPKα,P38MapKα和SIRT1的磷酸化激活PPARγ,其通过与PPARγ响应元素(PPRE)结合并增强PPARγ启动子活性来转动HO-1基因的转录。这些结果表明,Rosiglitazone诱导的HO-1表达通过PKCα/AMPKα/ P38 Mapkct / Sirt1依赖性脱乙酰化和HPapics中Ncor /PPARγ活化的破碎化。 HO-1的上调保护免受LPS引发的炎症反应,至少部分地通过NF-Kappa B.(c)2018年Elsevier Inc.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号